Kuala Lumpur, 9 March 2026 – Sunway Healthcare Holdings has set the final price for its highly anticipated initial public offering (IPO) at RM1.45 per share, paving the way to raise approximately RM2.86 billion (US$722 million) in what is expected to be Malaysia’s largest listing in nearly a decade.
The offering consists of 1.97 billion shares, representing 17.1% of the company’s enlarged share capital, valuing the healthcare provider at around RM16.7 billion upon listing. Trading of the shares is scheduled to begin on 18 March 2026 on Bursa Malaysia.
The IPO marks a significant milestone for Malaysia’s healthcare sector and capital market, highlighting strong investor appetite for healthcare assets as demand for private medical services continues to rise across the region.
Largest Malaysian IPO Since 2017
The listing will be the biggest on Bursa Malaysia since the 2017 flotation of Lotte Chemical Titan Holdings, which raised about RM3.8 billion.
The Sunway Healthcare offering includes 575 million new shares issued by the company, while 1.39 billion shares are being offered by existing shareholders, including Sunway City Berhad and Singapore sovereign wealth fund affiliate Greenwood Capital.
Strong institutional demand was reflected by the participation of prominent cornerstone investors such as AIA Group, Employees Provident Fund, and JPMorgan Asset Management.
Leading Private Healthcare Provider
Sunway Healthcare is a key healthcare arm of Sunway Group and operates several hospitals and medical facilities in Malaysia.
Its flagship facility, Sunway Medical Centre in Kuala Lumpur, is currently the largest private hospital in Malaysia, with 1,805 licensed beds as of January 2026.
The company provides a broad range of healthcare services including specialist treatments, tertiary care and medical tourism services.
Funds to Support Hospital Expansion
Proceeds from the IPO will primarily be used to expand existing hospitals and support new healthcare infrastructure projects, allowing the group to increase capacity and strengthen its position in Malaysia’s fast-growing healthcare sector.
Sunway Healthcare has also signalled potential plans to explore regional expansion opportunities, reflecting the growing demand for quality healthcare services across Southeast Asia.
Strong Growth in Healthcare Demand
The IPO comes amid strong financial growth for the group.
In 2024, Sunway Healthcare reported net profit of RM257.5 million, a 42% increase year-on-year, while revenue rose 27% to RM1.85 billion, driven by rising patient volumes and expansion of specialist medical services.
Healthcare has become one of the fastest-growing sectors in Malaysia, supported by demographic shifts, higher healthcare spending and increasing demand for private medical services.
Boost for Malaysia’s IPO Market
The listing is expected to provide a major boost to Malaysia’s capital markets, which have experienced renewed IPO activity in recent years.
According to market data, Bursa Malaysia raised US$2.36 billion from IPOs in 2025, ranking among Southeast Asia’s most active markets for new listings.
The Sunway Healthcare listing underscores investor confidence in Malaysia’s healthcare sector and highlights the growing importance of healthcare assets in regional capital markets.
